基本資料
種類: ETF
費用比率%: 0.49
資產淨值: 28.57
成立日期: 29/09/2025
 
分析
市值分佈:
64.58%
大市值
24.70%
中市值
9.54%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 343  
0%
 
100%
     10大 (8.14%)
代號 名稱 佔比% ▼ 持有日期
CYTKCytokinetics0.1230/10/2026
LMBLimbach Holdings0.1230/09/2026
PPGPPG Industries0.1230/10/2026
TSHATaysha Gene Therapies0.1130/10/2026
JBIJanus International Group0.1130/10/2026
ORICOric Pharmaceuticals0.1130/10/2026
TMDXTransMedics Group0.1130/10/2026
STOKStoke Therapeutics0.1130/09/2026
ATECAlphatec Holdings0.1130/10/2026
INSMInsmed Incorporated0.1130/10/2026
MBCMasterBrand0.1130/10/2026
ARVNArvinas0.1130/10/2026
MLYSMineralys Therapeutics0.1130/10/2026
RAPPRapport Therapeutics Inc.0.1130/10/2026
AHCOAdaptHealth Corp0.1130/10/2026
CCOICogent Communications Holdings0.1130/09/2026
MGTXMeiraGTx Holdings plc0.1130/10/2026
EVLVEvolv Technologies Holdings0.1130/10/2026
LGIHLGI Homes0.1030/10/2026
TTDTrade Desk (The)0.1030/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15   16    17    18  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.